About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Aggreguide A-100 ADP Assay Evaluation

Aggreguide A-100 ADP Assay Evaluation

NCT02112539·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Aggredyne, Inc.

Age

18–75

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

18-75

You may not be if

less than 60 kg
on antiplatelet meds other than aspirin
antiplatelet drugs contraindicated

The record

StatusCompleted

PhaseNo phase

Taking part150

StartedMar 2014

UpdatedApr 4, 2017

Conditions

Platelet Aggregation ADP Blockers

Where1

Juno Research
Houston, Texas, United States